Influx Healthtech Limited (NSE:INFLUX)

India · Delayed Price · Currency is INR

296.45

+11.15 (3.91%)

At close: Jul 31, 2026

88.28% (1Y)

Market Cap	6.86B +88.3%
Revenue (ttm)	1.47B +40.0%
Net Income	205.39M +53.7%
EPS	9.35 +27.0%
Shares Out	23.15M
PE Ratio	31.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,400
Open	286.00
Previous Close	285.30
Day's Range	285.50 - 299.00
52-Week Range	141.00 - 315.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 4, 2026

About Influx Healthtech

Influx Healthtech Limited operates as a contract development and manufacturing organization that provides a range of healthcare products in India. The company offers ayurvedic and herbal formulations in form of tablets, capsules, powders, liquid orals, ointments, creams, lotions, and other applications; veterinary feed supplements in form of tablets, liquid orals, oral sprays, powders, bolus, gels, ointments, and creams for animals; and home care products, including bathroom cleaners, floor cleansers, phenyle liquids, and other household cleani... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 2003

Employees 163

Stock Exchange National Stock Exchange of India

Ticker Symbol INFLUX

Full Company Profile

Financial Performance

In fiscal year 2026, Influx Healthtech's revenue was 1.47 billion, an increase of 40.04% compared to the previous year's 1.05 billion. Earnings were 205.39 million, an increase of 53.66%.

Financial Statements